Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Not Confirmed
Not Confirmed
08-10 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Not Confirmed
08-10 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/29/3141237/0/en/Banner-Year-for-Mesoblast-With-First-FDA-Product-Approval-and-Successful-Commercial-Launch-of-Ryoncil.html
27 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/27/3139878/0/en/Mesoblast-Financial-Results-and-Corporate-Update-Webcast.html
17 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/18/3117698/0/en/Successful-Commercial-Launch-of-Ryoncil.html
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/01/3107960/0/en/Mesoblast-and-FDA-Align-on-Key-Items-for-Revascor-Biologic-License-Application-in-Ischemic-Heart-Failure.html
11 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/12/3098012/0/en/Mesoblast-Maintains-Momentum-With-FDA-on-Accelerated-Approval-Pathway-for-Revascor-in-Ischemic-Heart-Failure-and-Label-Extension-for-Ryoncil-in-Adults-With-GvHD.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/15/3081759/0/en/FDA-Provides-Seven-Years-of-Orphan-Drug-Exclusive-Approval-for-Ryoncil.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE